CEO: Chris Owens
Sector: Medtech, Women’s Health
Location: California, USA
Investment Stage: Early growth
Investment Status: Current
Year Invested: 2015
Gynesonics is a women’s healthcare company focused on advancing women’s health, by developing minimally invasive, transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications. Gynesonics has developed the Sonata system for diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids. The Sonata system is CE marked. Sonata is approved for sale in the European Union, the United States, Australia, New Zealand, Hong Kong, Singapore and Malaysia. Gynesonics is a privately held company with headquarters in Redwood City, CA.
See Gynesonics related news here